{
  "id": 6486848,
  "title": "IL-33 Inhibitor Delivers in COPD Trials",
  "url": "https://urgent.news/2026/09/09/il-33-inhibitor-delivers-in-copd-trials",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-09T21:18:28.000Z",
  "source": {
    "name": "MedPage Today",
    "slug": "medpage-today",
    "url": "https://www.medpagetoday.com/meetingcoverage/ers/122943"
  },
  "original_language": "en",
  "account": null,
  "summary": "(MedPage Today) -- A broad population of people with chronic obstructive pulmonary disease (COPD), current and former smokers alike, experienced fewer exacerbations taking a first-in-class biologic targeting interleukin (IL)-33, a pair of double...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}